CRL - Company ID 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $213.77M | $194.61M | $276.77M | $233.91M | $241.21M | $228.42M |
| Short-term investments | - | - | - | - | $1.06M | $1.02M |
| Receivables | $708.86M | $720.91M | $780.38M | $752.39M | $642.88M | $617.74M |
| Inventory | $299.10M | $278.54M | $380.26M | $255.81M | $199.15M | $185.69M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.45B |
| $1.40B |
| $1.61B |
| $1.44B |
| $1.27B |
| $1.20B |
| Property, plant & equipment | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B | $1.12B |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B | $1.81B |
| Total assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B |
| Accounts payable | $148.80M | $140.34M | $168.94M | $205.91M | $198.13M | $122.47M |
| Total current liabilities | $1.12B | $994.10M | $1.06B | $1.09B | $1.03B | $839.75M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B |
| Retained earnings | $1.39B | $1.81B | $1.89B | $1.43B | $980.75M | $625.41M |
| Total equity | $3.16B | $3.46B | $3.60B | $2.98B | $2.53B | $2.11B |